Related Experiment Video
Updated: Jul 20, 2025

07:55
Ex Vivo Expansion and Genetic Manipulation of Mouse Hematopoietic Stem Cells in Polyvinyl Alcohol-Based Cultures
Published on: February 10, 2023
2.7K
Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations
Juan A Rubio-Lara1, Kyomi J Igarashi2, Shubhankar Sood3
1Department of Biology, University of York, York, England, UK.
Experimental Hematology
|August 5, 2023
Summary
Hematopoietic stem cell (HSC) expansion methods are crucial for overcoming their rarity in vivo. This review covers advances in polyvinyl alcohol-based, co-culture, and hydrogel HSC expansion techniques.
Area of Science:
- Hematology
- Stem Cell Biology
- Biotechnology
Background:
- Hematopoietic stem cells (HSCs) are vital for lifelong blood and immune cell production.
- HSC therapies, like transplantation, treat hematologic disorders but are limited by HSC rarity.
- Ex vivo expansion is essential for studying HSC biology and advancing therapies.
Purpose of the Study:
- To discuss recent advances in ex vivo hematopoietic stem cell expansion methods.
- To highlight technical considerations for improving HSC culture techniques.
- To summarize key findings from the 2022 ISEH Annual Meeting.
Main Methods:
- Polyvinyl alcohol (PVA)-based HSC expansion.
- Mesenchymal stromal cell-HSC co-culture systems.
- Two- and three-dimensional hydrogel-based HSC culture.
Main Results:
- Detailed review of three distinct ex vivo HSC expansion strategies.
- Discussion of technical challenges and innovations in each method.
- Synthesis of expert insights from the ISEH 2022 meeting.
Conclusions:
- Ex vivo expansion methods are critical for overcoming HSC scarcity.
- Advancements in PVA-based, co-culture, and hydrogel methods show promise for HSC research and therapy.
- Continued innovation in HSC culture is vital for clinical applications.
More Related Videos
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K

